o NoneEntity Type
0001205922
VACCINEX INC
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 VACCINEX, INC.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 VACCINEX, INC. 
Street Address 1Street Address 2
 1895 Mount Hope Avenue 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 Rochester NEW YORK 14620 585-271-2700 



3. Related Persons
Last NameFirst NameMiddle Name
ZaudererMaurice
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
RoyerScottE.
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
WatkinsRaymondE.
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
SmithErnestS.
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
FriedbergAlbertD.
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Bedrij StecykChrystyna
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
FriebergJacobB.
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
GoaterJ.Jeffrey
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
ManianBalaS.
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Van StrydonckGeraldE.
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
YannniBarbara
Street Address 1Street Address 2
1895 Mount Hope Avenue
CityState/Province/CountryZIP/Postal Code
RochesterNEW YORK14620
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
x $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
o Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-09-01 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 2000000 USD o Indefinite
Total Amount Sold $ 2000000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Vaccinex (NASDAQ:VCNX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Vaccinex Charts.
Vaccinex (NASDAQ:VCNX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Vaccinex Charts.

Vaccinex, Inc. News

Vaccinex Reports 2023 Financial Results and Provides Corporate Update
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Wednesday 27 March 2024 (1 month ago) • GlobeNewswire Inc.
Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
Wednesday 21 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Vaccinex, Inc. Announces Reverse Stock Split
Thursday 15 February 2024 (3 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)

More Vaccinex, Inc. News Articles